Research of TLR9 Inhibitor Influenced Release of IL-6 on Gastric Cancer Cell MGC803
|更新时间:2024-01-04
|
Research of TLR9 Inhibitor Influenced Release of IL-6 on Gastric Cancer Cell MGC803
Chinese Journal of Experimental Traditional Medical FormulaeVol. 19, Issue 6, Pages: 267-270(2013)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2013
稿件说明:
移动端阅览
Li Rui, ZHANG Yan-li, LI Ya-lan, et al. Research of TLR9 Inhibitor Influenced Release of IL-6 on Gastric Cancer Cell MGC803[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(6): 267-270.
DOI:
Li Rui, ZHANG Yan-li, LI Ya-lan, et al. Research of TLR9 Inhibitor Influenced Release of IL-6 on Gastric Cancer Cell MGC803[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(6): 267-270.DOI:
Research of TLR9 Inhibitor Influenced Release of IL-6 on Gastric Cancer Cell MGC803
Objective: To investigate the expression of TLR9 in gastric cancer cell line MGC803 and the influence of TLR9 inhibitor chloroquine (chloroquine
CQ) treated the MGC803 cell in different period on the secretion of interleukin-6(IL-6). Method: To Measure TLR9 expression in MGC803 gastric cancer cell line by immunofluorescence staining.Observed the effect of CQ in MGC803 cell at 24
48
72 h by CCK-8 assay.The bioactivity of IL-6 in the MGC803 cell suspension treated with different concentration CQ in three period was detected by ELISA. Result: MGC803 cells expressed TLR9.Different concentration of CQ could inhibit the growth of MGC803 cells (P<0.05) at different time point.200 mg·L-1 CQ decreased the bioactivity of IL-6 in 24
48
72 h
but 50
100 mg·L-1 CQ suppressed IL-6 expression only after 72 h(P<0.05). Conclusion: MGC803 cells expressed TLR9 and TLR9 inhibitor CQ could inhibit IL-6 bioactivity.